These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32347269)

  • 1. Tandem post-synthetic modification of a zeolitic imidazolate framework for CXCR4-overexpressed esophageal squamous cell cancer imaging and therapy.
    Cao Y; Jiang Z; Li Y; Wang Y; Yang Y; Akakuru OU; Li J; Wu A
    Nanoscale; 2020 Jun; 12(24):12779-12789. PubMed ID: 32347269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combination of glioma in vivo imaging and in vivo drug delivery by metal-organic framework based composite nanoparticles.
    Pan YB; Wang S; He X; Tang W; Wang J; Shao A; Zhang J
    J Mater Chem B; 2019 Dec; 7(48):7683-7689. PubMed ID: 31778139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manganese-Zeolitic Imidazolate Frameworks-90 with High Blood Circulation Stability for MRI-Guided Tumor Therapy.
    Jiang Z; Yuan B; Qiu N; Wang Y; Sun L; Wei Z; Li Y; Zheng J; Jin Y; Li Y; Du S; Li J; Wu A
    Nanomicro Lett; 2019 Jul; 11(1):61. PubMed ID: 34138009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of Solubility Enhancement of Poorly Water-Soluble Drugs Triggered by Zeolitic Imidazolate Frameworks.
    Ohshima K; Ohsaki S; Nakamura H; Watano S
    Chem Pharm Bull (Tokyo); 2022; 70(5):383-390. PubMed ID: 35491195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocompatible and biodegradable zeolitic imidazolate framework/polydopamine nanocarriers for dual stimulus triggered tumor thermo-chemotherapy.
    Wu Q; Niu M; Chen X; Tan L; Fu C; Ren X; Ren J; Li L; Xu K; Zhong H; Meng X
    Biomaterials; 2018 Apr; 162():132-143. PubMed ID: 29448141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual ATP and pH responsive ZIF-90 nanosystem with favorable biocompatibility and facile post-modification improves therapeutic outcomes of triple negative breast cancer in vivo.
    Jiang Z; Wang Y; Sun L; Yuan B; Tian Y; Xiang L; Li Y; Li Y; Li J; Wu A
    Biomaterials; 2019 Mar; 197():41-50. PubMed ID: 30640136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polydopamine-reinforced magnetization of zeolitic imidazolate framework ZIF-7 for magnetic solid-phase extraction of polycyclic aromatic hydrocarbons from the air-water environment.
    Zhang S; Yao W; Ying J; Zhao H
    J Chromatogr A; 2016 Jun; 1452():18-26. PubMed ID: 27234848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bimetallic Zeolitic Imidazolate Framework as an Intrinsic Two-Photon Fluorescence and pH-Responsive MR Imaging Agent.
    Zhao G; Wu H; Feng R; Wang D; Xu P; Wang H; Guo Z; Chen Q
    ACS Omega; 2018 Aug; 3(8):9790-9797. PubMed ID: 31459108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor microenvironment responsive
    Liang M; Zhou W; Zhang H; Zheng J; Lin J; An L; Yang S
    J Mater Chem B; 2023 May; 11(19):4203-4210. PubMed ID: 37114335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural drug physcion encapsulated zeolitic imidazolate framework, and their application as antimicrobial agent.
    Soomro NA; Wu Q; Amur SA; Liang H; Ur Rahman A; Yuan Q; Wei Y
    Colloids Surf B Biointerfaces; 2019 Oct; 182():110364. PubMed ID: 31352254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zeolitic imidazolate framework (ZIF)-derived porous carbon materials for supercapacitors: an overview.
    Ahmad R; Khan UA; Iqbal N; Noor T
    RSC Adv; 2020 Nov; 10(71):43733-43750. PubMed ID: 35519688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zeolitic Imidazole Framework (ZIF) Nanospheres for Easy Encapsulation and Controlled Release of an Anticancer Drug Doxorubicin under Different External Stimuli: A Way toward Smart Drug Delivery System.
    Adhikari C; Das A; Chakraborty A
    Mol Pharm; 2015 Sep; 12(9):3158-66. PubMed ID: 26196058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Progress and Prospect of Zeolitic Imidazolate Frameworks in Cancer Therapy, Antibacterial Activity, and Biomineralization.
    Maleki A; Shahbazi MA; Alinezhad V; Santos HA
    Adv Healthc Mater; 2020 Jun; 9(12):e2000248. PubMed ID: 32383250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tandem postsynthetic metal ion and ligand exchange in zeolitic imidazolate frameworks.
    Fei H; Cahill JF; Prather KA; Cohen SM
    Inorg Chem; 2013 Apr; 52(7):4011-6. PubMed ID: 23516974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, structure, and carbon dioxide capture properties of zeolitic imidazolate frameworks.
    Phan A; Doonan CJ; Uribe-Romo FJ; Knobler CB; O'Keeffe M; Yaghi OM
    Acc Chem Res; 2010 Jan; 43(1):58-67. PubMed ID: 19877580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Versatile Competitive Coordination Strategy for Tailoring Bioactive Zeolitic Imidazolate Framework Composites.
    Wu X; Xiong J; Liu S; Zong MH; Lou WY
    Small; 2021 May; 17(20):e2007586. PubMed ID: 33825336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metal-organic frameworks of zeolitic imidazolate framework-7 and zeolitic imidazolate framework-60 for fast mercury and methylmercury speciation analysis.
    Xu F; Kou L; Jia J; Hou X; Long Z; Wang S
    Anal Chim Acta; 2013 Dec; 804():240-5. PubMed ID: 24267088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zeolitic imidazolate frameworks for use in electrochemical and optical chemical sensing and biosensing: a review.
    Zhang J; Tan Y; Song WJ
    Mikrochim Acta; 2020 Mar; 187(4):234. PubMed ID: 32180011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zeolitic imidazolate frameworks: From bactericidal properties to tissue regeneration.
    Kermanian M; Nadri S; Mohammadi P; Iravani S; Ahmadi N; Alinezhad V; Shokrgozar MA; Haddad M; Mostafavi E; Maleki A
    J Control Release; 2023 Jul; 359():326-346. PubMed ID: 37290724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromium-Doped Zinc Gallogermanate@Zeolitic Imidazolate Framework-8: A Multifunctional Nanoplatform for Rechargeable In Vivo Persistent Luminescence Imaging and pH-Responsive Drug Release.
    Lv Y; Ding D; Zhuang Y; Feng Y; Shi J; Zhang H; Zhou TL; Chen H; Xie RJ
    ACS Appl Mater Interfaces; 2019 Jan; 11(2):1907-1916. PubMed ID: 30566326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.